Catégories
-
Adhesives
5
Amines
93
Amino Acids
180
Analytical Reagents
669
Antibiotics
252
Bioactive Small Molecules
718
Aroma Chemicals
205
Biochemicals
1011
Boronic Acids
4
Buffers
97
Building Blocks
1780
Carbohydrates
176
Catalysts
99
Chiral Compounds
54
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
250
Flavours and Fragrance Materials
203
Fluorinated Products
42
Furans
5
Gases in Solution
50
Grignard Reagents
19
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
324
Ion-Pair Reagents
24
Ligands
79
Organics
1303
Oxazoles
3
Peptide Reagents
90
Phenols
44
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
44
Reagents
97
Research Organics & Inorganics
751
Salts
282
Sealing Compounds
1
Sherclin
2
Solvents
121
Stains & Indicators
289
Sugars
63
Tailor-made solutions
3
Testing Standards
4
Uncategorised
168
Water Analysis
10
Retigabine
(27172933 | 150812-12-7)
CAS: | 150812-12-7 |
---|---|
Formule moléculaire: | C16H18FN3O2 |
Masse moléculaire: | 303.33 |
Disponibilité: | Vérifier la disponibilité |
---|---|
Téléchargements: | | |
Ce produit est soumis à une surtaxe dangereuse. Le montant exact sera confirmé par notre équipe commerciale.
27172933-1g | 1g | £127.70 | |
Commande en vrac |
27172933-1g | 1g | €178.80 | |
Commande en vrac |
27172933-1g | 1g | $191.60 | |
Commande en vrac |
Fiche de données de sécurité
Certificat d'analyse
Détails du produit
Product Code | 27172933 | ||||
Product Name | Retigabine | ||||
Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
CAS | 150812-12-7 | ||||
Molecular Formula | C16H18FN3O2 | ||||
Molecular Weight | 303.33 | ||||
Storage Details | 2 to 8 °C | ||||
Harmonised Tariff Code | 2924297099 |
Spécifications du produit
Total impurity | ≤ 1.0% | ||||
Purity (HPLC) | ≥ 99.0% | ||||
Single Impurity | ≤ 0.5% | ||||
Identification | Conforms to reference | ||||
Appearance | Grey to pink powder |
Informations sur la sécurité
Pictograms |
|
||||
Signal word | warning | ||||
Hazard statements |
|
||||
Precautionary statements |
|